U
MRK icon

UBS’s Merck MRK Stock Holding History

UBS’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$25.7M Buy
453,753
+149,361
+49% +$8.39M 0.02% 802
2014
Q2 		$16.8M Sell
304,392
-10,113
-3% -$552K 0.01% 988
2014
Q1 		$17M Buy
314,505
+149,655
+91% +$7.75M 0.02% 895
2013
Q4 		$7.87M Buy
164,850
+7,545
+5% +$345K 0.01% 1463
2013
Q3 		$7.15M Sell
157,305
-42,339
-21% -$1.93M 0.01% 1406
2013
Q2 		$8.85M Buy
+199,644
New +$8.92M 0.01% 1133

Other funds holding MRK

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS's MRK Position: Q3 2014 in Review

UBS increased its Merck (MRK) stake by 13% in Q3 2014, buying an estimated $76.6M and bringing the position to 11,736,426 shares worth $664M. The position accounts for 0.49% of the portfolio, ranked #22.

UBS first reported a position in MRK in Q2 2013 and has held it in 6 quarters since. 1,618 funds tracked by Wall St. Rank hold MRK as of Q3 2014.

  • UBS held 11,736,426 shares of Merck worth $664M as of Q3 2014.
  • UBS bought 1,364,523 Merck shares in Q3 2014, an estimated $76.6M.
  • Merck made up 0.49% of UBS's portfolio in Q3 2014, its #22 holding.
  • UBS first reported a position in Merck in Q2 2013 and has held it in 6 quarters since.
  • 1,618 funds tracked by Wall St. Rank held Merck as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.